Main Menu

Professional activities

Qualifications

FRCP 2016, Royal College of Physicians, London.

FRACR (Hon) October 1999, .

FRCR (UK) October 1977, .

MRCP (UK) October 1974, .

MB BS London October 1972, .

BSc (Hons) London July 1969, .

Awards, Prizes or Honours

Weiss Medal, Association of Radiation Research, 2017.

Berkeley Fellowship, Gonville and Caius College, Cambridge & Middlesex Hospital London, 1997.

Rohan Williams Medal, Part II (final) FRCR, Royal College of Radiologists, 1997.

Travelling Fellowship, Cancer Research Campaign, 1987.

Rohan Williams Travelling Professorship, Australian College of Radiologists & Royal College of Radiologists, 1996-1997.

Honorary Life Member, Canadian Association of Radiation Oncology, 1996.

Honorary Life Fellow, Royal Australasian College of Radiologists, 1999.

George Edelstyn Memorial Lecture, Royal College of Radiologists, 2007.

Senior Investigator, National Institute of Health Research, 2007-2013.

George Edelstyn Memorial Lecture, National Cancer Research Institute, 2013.

Jonathan S.T. Sham Visiting Professor, Hong Kong University, 2014.

Senior Investigator (Emeritus), National Institute of Health Research, 2014.

Jean H. Lubrano Distinguished Visiting Scholar, Susan F. Smith Centre for Women’s Cancer, Dana Farba/Havard Cancer Institute, Boston., 2015.

ESTRO Lifetime Achievement Award, ESTRO, 2015.

Klaus Breuer Gold Medal, European Society of Radiotherapy & Oncology, European Society of Radiotherapy & Oncology, 2007.

Fellow of the European Academy of Cancer Sciences, European Academy of Cancer Sciences, 2011.

Emmanuel van de Scheuren Memorial Lecture, European Breast Cancer Congress, 2010.

Honorary Life Member, Belgian Society for Radiation Oncology, , 2008.

President’s Medal, The Royal College of Radiologists, , 2003.

Editorial Boards

Radiotherapy & Oncology: Reviewer, 1985.

European Journal of Cancer: Reviewer, 1989.

Radiotherapy & Oncology: Editorial Board, 1990-1995.

British Journal of Cancer: Reviewer, 1991.

British Journal of Radiology: Reviewer, 1991.

Acta Oncology: Advisory Board, 1992-1996.

Journal of Cancer Research and Therapeutics: Consulting Editor (Europe), 2005.

External Committees

Independent Data Monitorin Committee, Chairman, Medical Research Council, 2014.

International Committee, Member, 14th St Gallen Breast Cancer Conference, 2014-2015.

Organising Committee, Member, ECCO17-ESMO38-ESTRO32, 2011-2013.

Executive Committee, Member, ECCO17-ESMO38-ESTRO32, 2011-2013.

Scientific Programme Committee, Member, ECCO16-ESMO36, 2010-2011.

Data and Safety Monitoring Board, Member, PORTEC-3 Data and Safety Monitoring Board, 2008.

Scientific Program Committee, . 2nd ESTRO Morbidity Conference, 2008-2009.

Board of ESTRO, Memeber, European Society for Therapeutic Radiology and Oncology, 2008.

Review Committee, Member, Baromedical Research Foundation, 2006.

College of Senior Investigators, Senior Investigator Emeritus Status, The National Institute for Health Research, 2014.

IDMC, Committee member, SCORAD III IDMC, 2011.

Experts Committee, Member, MRC, 2006-2010.

Database, . Best Doctors 2006-2007 database, 2006-2007.

Feasibility Study Committee, Member, Cancer Research UK, 2005-2008.

Health Services and Public Health Research Board, Member, MRC, 2005-2008.

Validation Panel, 2005, Institute of Cancer Research MSc in Oncology

Steering Committee, Member, Academic Radiotherapy & Oncology Network (ACORRN), 2005.

Breast Cancer Evaluation Board, Faculty Member, Faculty of 1000 Medicine, 2005.

Data Monitoring Committee, Chair, BRCA Trial: Breakthrough Breast Cancer & Cancer Research UK Genetic Breast Cancer Trial. A randomised phase II pilot trial of docetaxel versus carboplatin for patients with relapsed genetic breast cancer., 2005-2010.

Breakthroughs Panel of Clinical Experts, . MRC: London Lung Cancer Group Study 14 – A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without Thalidomide in advanced NSCLC, 2004-2006.

Member of Breakthroughs Panel of Clinical Experts (2004 – 2006), Member, MRC: London Lung Cancer Group Study 14 – A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without Thalidomide in advanced NSCLC, 2004-2006.

Data Monitoring and Ethics Committee, Member, MRC: London Lung Cancer Group Study 14 – A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without Thalidomide in advanced NSCLC, 2003-2007.

Data Monitoring and Ethics Committee, . MRC: London Lung Cancer Group Study 12 – A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without Thalidomide in SCLC, 2003-2007.

Expert Advisory Committee, Member, Department of Health, 2003.

ICR-CTSU Clinical Advisory, . A Trial of Sentinel Node Guidance Axillary Therapy compared with Standard Axillary Therapy in Early Breast Cancer (ALMANAC), 2002-2012.

Data Monitoring Committee, Member, A Trial of Sentinel Node Guidance Axillary Therapy compared with Standard Axillary Therapy in Early Breast Cancer (ALMANAC), 2002-2012.

Data Monitoring and Ethics Committee, . A Study in the Treatment of Endometrial Cancer (ASTEC), 2001-2012.

Editorial Group, . Department of Health, National Cancer Guidance: Breast Cancer Update, 2000-2001.

Trial Steering Committee, . UKCCCR Tamoxifen Prevention Trial (IBIS), 1996-2010.

Protocol Working Party, . UKCCCR Standardisation of Radiotherapy (START) Trial, 1995-1998.

Trial Management Group, . UKCCCR Adjuvant Breast Cancer (ABC) Trial, 1993-2010.

Protocol Working Party, . UKCCCR Adjuvant Breast Cancer (ABC) Trial, 1992-1993.

Breast Clinical Studies Group, Chariman, National Cancer Research Institute (NCRI), 2001-2004.

National Cancer Research Institute, Chief investigator & Chair, Trials Management Group, START TRials A & B, 1998-2006.

IMPORT Trials Management Group, Chairman (& Chief Investigator), IMPORT LOW & HIGH Trials, 2003-2013.

FAST-Forward Trial Management Group, Chairman, National Cancer Research Network, 2009.

Scientific Committee, Co-Chair of Scientific Committee, European Cancer Congress, 2011-2013.

College of Senior Investigators, Member, The National Institute for Health Research, 2008-2014.

Breast Cancer Pathway Group, Member, London Cancer Alliance, 2011.

FAST Trial Management Group, Chairman, National Cancer Research Network, 2003.

National Radiotherapy Advisory Group, Member, UK Government, 2005-2010.